Last checked at 14 Sep 2023 16:26
14 September 2023
Belluscura plc
("BELL" or the "Company")
Result of AGM
Belluscura plc (AIM: BELL) announces that at the Annual General Meeting ("AGM") held earlier today all the resolutions put to the meeting were duly approved by shareholders:
Resolution (*indicates special resolution) | Votes for | % of shares voted | Votes against | % of shares voted | Votes withheld |
Resolution 1: To receive and adopt the report of the directors and the audited accounts of the Company for the period ended 31 December 2022 | 52,474,602 | 99.67% | 175,911 | 0.33% | 0 |
Resolution 2: To re-elect Mr David Poutney as a director of the Company. | 52,471,268 | 99.67% | 175,911 | 0.33% | 3,334 |
Resolution 3. To re-elect Dr Patrick Strollo as a director of the Company. | 52,628,453 | 99.96% | 22,060 | 0.04% | 0 |
Resolution 4: To re-appoint Gerald Edelman LLP as auditors.
| 52,628,453 | 99.96% | 22,060 | 0.04% | 0 |
Resolution 5: To authorise the directors to determine the remuneration of the auditors. | 52,628,453 | 99.96% | 22,060 | 0.04% | 0 |
Resolution 6: To grant the directors authority to allot shares pursuant to Section 551 of the Companies Act 2006 and grant rights to subscribe for, or convert any security into, shares. | 52,601,892 | 99.91% | 48,621 | 0.09% | 0 |
Resolution 7*: To dis-apply pre-emption rights pursuant to Section 570 of the Companies Act 2006. | 52,601,892 | 99.91% | 48,621 | 0.09% | 0 |
Resolution 8*: To authorise the directors to make market purchases. | 52,640,513 | 99.98% | 10,000 | 0.02% | 0 |
*Special resolutions
For further information please contact:
Belluscura plc | Tel: +44 (0)20 3128 8100 |
Adam Reynolds, ChairmanRobert Rauker, Chief Executive OfficerAnthony Dyer, Chief Financial Officer | |
SPARK Advisory Partners Limited Nominated Adviser | Tel: +44 (0)20 3368 3550 |
Neil Baldwin / Jade Bayat | |
Dowgate Capital Limited Broker | Tel: +44 (0)20 3903 7715 |
James Serjeant / Russell Cook | |
MHP Financial PR & Investor Relations | Tel: +44 (0)20 3128 8100 email: Belluscura@mhpgroup.com |
Katie Hunt / Matthew Taylor |
About Belluscura plc (www.belluscura.com)
Belluscura is a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organisations.